99% Savings - Buy Just @1 Rs X
Kefnir 125 Mg Suspension is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
2 - 12 years (Child) |
|
Is the use of Kefnir 125 Mg Suspension safe for pregnant women?
There are no side effects of Kefnir in pregnant women.
Is the use of Kefnir 125 Mg Suspension safe during breastfeeding?
Kefnir does not show any side effects in breastfeeding women.
What is the effect of Kefnir 125 Mg Suspension on the Kidneys?
Kefnir rarely harms the kidneys.
What is the effect of Kefnir 125 Mg Suspension on the Liver?
Kefnir is completely safe for the liver.
What is the effect of Kefnir 125 Mg Suspension on the Heart?
You can take Kefnir without any fear of damage to the heart.
If you are suffering from any of the following diseases, you should not take Kefnir 125 Mg Suspension unless your doctor advises you to do so -
Is this Kefnir 125 Mg Suspension habit forming or addictive?
Kefnir 125 Mg Suspension does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Kefnir 125 Mg Suspension as you may feel sleepy.
Is it safe?
Kefnir 125 Mg Suspension should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of Kefnir 125 Mg Suspension in mental disorders is not effective.
Interaction between Food and Kefnir 125 Mg Suspension
Some foods when eaten with Kefnir 125 Mg Suspension can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Kefnir 125 Mg Suspension
Due to lack of research, there is no information about the side effects of taking Kefnir 125 Mg Suspension with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-310
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Omnicef® (cefdinir)